Heartmate XVE destination therapy for end-stage heart failure in a patient with human immunodeficiency virus.

Interact Cardiovasc Thorac Surg

Division of Cardiothoracic Surgery, Richard M. Ross Heart Hospital, The Ohio State University Medical Center, Columbus, OH 43210, USA.

Published: November 2009

Cardiac dysfunction is a known predictor of survival in patients with acquired immunodeficiency syndrome. In this report, we describe a human immunodeficiency virus (HIV)-infected patient with worsening heart failure who was managed successfully for 16 months with placement of a left ventricular assist device.

Download full-text PDF

Source
http://dx.doi.org/10.1510/icvts.2009.212076DOI Listing

Publication Analysis

Top Keywords

heart failure
8
human immunodeficiency
8
immunodeficiency virus
8
heartmate xve
4
xve destination
4
destination therapy
4
therapy end-stage
4
end-stage heart
4
failure patient
4
patient human
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!